Affinity Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Affinity Capital Advisors's MRK Position: Q3 2026 in Review
Affinity Capital Advisors increased its Merck (MRK) stake by 18% in Q3 2026, buying an estimated $124K and bringing the position to 5,884 shares worth $857K. The position accounts for 0.1% of the portfolio, ranked #83.
Affinity Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 28 quarters since. 1,277 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Affinity Capital Advisors held 5,884 shares of Merck worth $857K as of Q3 2026.
- Affinity Capital Advisors bought 900 Merck shares in Q3 2026, an estimated $124K.
- Merck made up 0.1% of Affinity Capital Advisors's portfolio in Q3 2026, its #83 holding.
- Affinity Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 28 quarters since.
- 1,277 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Affinity Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.